GlaxoSmithKline PLC ADR Earnings

The next earnings date for GlaxoSmithKline PLC ADR is October 29, 2025.

They are scheduled to announce earnings before the market opens that day.

Analyst Estimates of GlaxoSmithKline PLC ADR Earnings

Report DateEstimated Earnings Per Share
10/29/2025$1.17

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

GlaxoSmithKline PLC ADR Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
07/29/2025Before Market------
04/29/2025Before Market$1.2015.64%
02/05/2025Before Market$0.5818.79%
10/30/2024Before Market$1.294.88%
07/31/2024Before Market$1.1011.11%
05/01/2024Before Market$1.0919.78%
01/31/2024Before Market$0.72-5.26%
11/01/2023Before Market$1.2812.28%
07/26/2023Before Market$0.9711.49%
04/26/2023Before Market$0.909.76%
02/01/2023Before Market$0.6122.00%
11/02/2022Before Market$1.1014.58%
07/27/2022Before Market$0.8719.18%
04/29/2022After Market$1.0917.20%
02/09/2022Before Market$0.866.17%
10/27/2021Before Market$1.2624.75%
07/28/2021Before Market$0.9853.13%
04/28/2021Before Market$0.793.95%
02/03/2021Before Market$0.77-3.75%
10/28/2020Before Market$1.2525.00%
07/29/2020Before Market$0.57-10.94%
04/29/2020Before Market$1.2034.83%
02/05/2020Before Market$0.80-4.76%
10/30/2019Before Market$1.1912.26%
07/24/2019Before Market$0.9926.92%
05/01/2019Before Market$0.9820.99%
02/06/2019Before Market$1.0120.24%
10/31/2018Before Market$1.154.55%
07/25/2018Before Market$0.991.02%
04/25/2018After Market$0.860.00%
02/07/2018Before Market$0.895.95%
10/25/2017Before Market$1.061.92%
07/26/2017Before Market$0.882.33%
04/26/2017Before Market$0.790.00%
02/08/2017Before Market$0.811.25%
10/26/2016Before Market$1.0613.98%
07/27/2016After Market$0.8624.64%
04/27/2016Before Market$0.696.15%
02/03/2016Before Market$0.6913.11%
10/28/2015Before Market$0.8820.55%
07/29/2015Before Market$0.09---
05/06/2015After Market$5.03---
02/04/2015Before Market$0.67---
10/22/2014Before Market$1.16132.00%
07/23/2014---$0.57---
04/30/2014---$0.57---
02/05/2014---$1.210.83%
10/23/2013---$0.76---
07/24/2013---$0.82---
04/24/2013---$0.77---
02/06/2013---$1.3044.44%
10/31/2012---$0.89---
07/25/2012---$1.04-3.70%
04/25/2012---$1.06-7.02%
02/07/2012---$0.9818.07%
10/26/2011---$1.13-2.59%
07/26/2011---$0.89-7.29%
04/27/2011---$1.19-4.03%
02/03/2011---$-0.53---
10/21/2010---$0.98---
07/21/2010---$-0.22---
04/28/2010---$1.01---
02/04/2010---$1.30---
10/28/2009---$1.07---
07/22/2009---$1.11---
04/22/2009---$0.80---
02/05/2009---$0.75---
10/22/2008---$0.93---
07/23/2008---$1.21---
04/23/2008---$1.20---
02/07/2008---$1.2519.05%
10/24/2007---$1.190.00%
07/25/2007---$1.180.00%
04/25/2007---$1.331.53%
02/08/2007---$1-4.76%
10/26/2006---$1.14---
07/26/2006---$1.05---
04/27/2006---$1.15---
02/08/2006---$0.866.17%
10/27/2005---$0.95-1.04%
07/28/2005---$0.94---
04/28/2005---$1-3.85%
02/10/2005---$0.81-3.57%
10/28/2004---$0.9911.24%
07/27/2004---$0.91-3.19%
04/29/2004---$0.893.49%
02/06/2004---$0.68-16.05%
10/22/2003---$0.837.79%
07/23/2003---$0.9813.95%
04/30/2003---$0.8616.22%
02/12/2003---$0.81-1.22%
10/23/2002---$0.640.00%
07/25/2002---$0.81-1.22%
04/25/2002---$0.681.49%
02/14/2002---$0.741.37%
10/23/2001---$0.571.79%
07/24/2001---$0.710.00%
05/18/2001---$0.595.36%
07/01/2000---$0.65-41.96%
06/30/2000---$0.52-41.57%
02/16/2000---$1.11-3.48%
08/02/1999---$1.04-0.95%
02/18/1999---$1.169.43%
08/12/1998---$0.96-3.03%
08/04/1997---$1.200.84%
03/07/1997---$1.06-6.19%
08/05/1996---$1.115.71%
03/06/1996---$1.063.92%
02/07/1995---$0.9910.00%
09/08/1994---$0.74-8.64%
09/14/1993---$0.887.32%

More About GlaxoSmithKline PLC ADR

Website
https://www.gsk.com
Country
USA
Full Time Employees
68,629

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in London, United Kingdom.

“GlaxoSmithKline PLC ADR Earnings” Can Refer to the GlaxoSmithKline PLC ADR Earnings Date

Some people say “GlaxoSmithKline PLC ADR earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my GlaxoSmithKline PLC ADR position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning GlaxoSmithKline PLC ADR Stock on the Earnings Date

If you own GlaxoSmithKline PLC ADR stock (GSK) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for GlaxoSmithKline PLC ADR might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading GlaxoSmithKline PLC ADR shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Owning GlaxoSmithKline PLC ADR Options on the Earnings Date

If you own GlaxoSmithKline PLC ADR options on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

In addition, the extrinsic values of GlaxoSmithKline PLC ADR options that overlap earnings dates are often higher than other days of the year. In other words, the premiums you pay to own GlaxoSmithKline PLC ADR options are typically higher during that period. In particular, they are frequently higher immediately before earnings and on the day they’re announced.

This makes sense considering that prices are often more volatile on earnings dates for GlaxoSmithKline PLC ADR. That potential volatility is a key factor that affects the premium cost of owning options.

Once the earnings announcement is done and the anticipated price volatility has gone down, the extrinsic values of GlaxoSmithKline PLC ADR options often go down. This is sometimes referred to as volatility crush.

Learning More GlaxoSmithKline PLC ADR Earnings

You can contact us any time if you would like to ask questions about GlaxoSmithKline PLC ADR earnings or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.